Broadcom vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 89)

Broadcom

LeaderSemiconductors

Custom ASIC

Palo Alto semiconductor + infrastructure software (NASDAQ: AVGO) at $51.6B FY2024 revenue; AI revenue $12.2B (+220%) from custom XPUs and networking with VMware $69B 2023 acquisition competing with NVIDIA for AI data center infrastructure.

AI VisibilityBeta
Overall Score
A89
Category Rank
#1 of 2
AI Consensus
67%
Trend
stable
Per Platform
ChatGPT
80
Perplexity
87
Gemini
95

About

Broadcom Inc. is a Palo Alto, California-headquartered global semiconductor and infrastructure software company — publicly traded on NASDAQ (NASDAQ: AVGO) at approximately $800 billion market capitalization — reporting $51.6 billion in fiscal year 2024 revenue (ended October 2024, 44% year-over-year growth) with AI-related revenue reaching $12.2 billion (220% growth) from custom AI accelerators (XPUs) and networking chips for hyperscale cloud providers. Following the $69 billion VMware acquisition completed in November 2023 (the largest enterprise technology acquisition ever), Broadcom's revenue is now 58% semiconductor and 42% infrastructure software (VMware by Broadcom, CA Technologies products, and Symantec enterprise security). Under CEO Hock Tan's acquisition-driven strategy since 2006, Broadcom has transformed from a moderate-sized fabless semiconductor company into a diversified technology powerhouse with 37,000+ employees. Roots trace to HP Associates (1961), then Agilent Technologies, then Avago Technologies, which acquired Broadcom Corporation in 2016.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

89
Overall Score
90
#1
Category Rank
#9
67
AI Consensus
60
stable
Trend
stable
80
ChatGPT
99
87
Perplexity
99
95
Gemini
83
90
Claude
96
89
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.